Monte Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-52,026
Closed -$3.03M 63
2020
Q4
$3.03M Sell
52,026
-3,506
-6% -$212K 2.06% 31
2020
Q3
$3.51M Buy
55,532
+4,381
+9% +$304K 2.65% 14
2020
Q2
$3.94M Buy
51,151
+3,324
+7% +$255K 3.11% 8
2020
Q1
$3.58M Sell
47,827
-14,164
-23% -$979K 3.46% 2
2019
Q4
$4.03M Buy
61,991
+6,558
+12% +$427K 2.97% 6
2019
Q3
$3.51M Buy
55,433
+2,154
+4% +$141K 2.83% 10
2019
Q2
$3.6M Buy
53,279
+3,042
+6% +$200K 3.05% 6
2019
Q1
$3.27M Buy
50,237
+6,139
+14% +$408K 2.86% 13
2018
Q4
$2.76M Buy
44,098
+960
+2% +$67.1K 2.92% 13
2018
Q3
$3.33M Buy
43,138
+3,569
+9% +$270K 3.12% 9
2018
Q2
$2.8M Buy
39,569
+1,877
+5% +$133K 2.85% 13
2018
Q1
$2.84M Buy
37,692
+1,558
+4% +$124K 2.97% 11
2017
Q4
$2.59M Buy
+36,134
New +$2.74M 2.63% 15

Other funds holding GILD

Monte Financial Group's GILD Position: Q1 2021 in Review

Monte Financial Group sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 52,026 shares — an estimated $3.03M sold.

Monte Financial Group first reported a position in GILD in Q4 2017 and held it in 13 quarters. The position peaked at $4.03M in Q4 2019. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • Monte Financial Group reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
  • Monte Financial Group sold 52,026 Gilead Sciences shares in Q1 2021, an estimated $3.03M.
  • Monte Financial Group first reported a position in Gilead Sciences in Q4 2017 and held it in 13 quarters.
  • Monte Financial Group's Gilead Sciences position peaked at $4.03M in Q4 2019.
  • 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Monte Financial Group's 13F filing for Q1 2021, filed 30 Apr 2021.